TY - JOUR
AR - COR-2022-4-103
TI - Review Article on Epithelial Ovarian Cancer with Peritoneal Metastasis
AU - K., Grammatikakis
AU - E., Halkia
AU - K. , Patsouras
JO - Clinical Oncology and Research
PY - 2022
DA - Fri 21, Oct 2022
SN - 2613-4942
DO - http://dx.doi.org/10.31487/j.COR.2022.04.03
UR - https://www.sciencerepository.org/review-article-on-epithelial_COR-2022-4-103 
KW - Ovarian, cancer, chemotherapy, intraperitoneal chemotherapy, upfront surgery, visceral segmental serosectomy (VSS), peritoneal cancer index (PCI), small bowel, carcinomatosis, cytoreductive surgery, ovarian cancer, CA125, screening, debulking, immunotherapy, residual tumor, malignant ascites
AB - Introduction: Many advances have emerged in the management of peritoneal metastases of ovarian cancer origin, widely known as the most common gynaecological malignancy. This review is an update of the current management algorithm of peritoneal carcinomatosis of ovarian cancer, including screening methods, biomarkers and surgical techniques, in an effort to shed some light into this difficult to treat malignancy.
Objective: To assess awareness in the management of epithelial ovarian cancer (EOC) with peritoneal metastasis with updated therapeutic standpoints.